Related Experiment Video
Updated: Jun 29, 2025
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Review Deciphering the Potential of Nanotherapeutics in Lung Cancer Management
Prashant Chauhan1, Pratibha Pandey1, Seema Ramniwas2
1Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, Uttar Pradesh, India.
Abstract:
Lung cancer remains a formidable challenge in oncology, necessitating the development of more effective prognostic and diagnostic techniques due to inefficient conventional therapeutic approaches and inadequate methods for early lung cancer diagnosis. Despite immense progress in the development of innovative strategies to alleviate the impact of this devastating disease, the outcomes, unfortunately, remain unsatisfactory, particularly in targeted drug delivery methods. Consequently, nanotechnology has emerged as a revolutionary force in cancer research to develop more effective targeted drug delivery tools due to its extraordinary capacity at the atomic and molecular levels. It has appeared as a beacon of hope in this area of unmet need, providing innovative ways for the prognosis and diagnosis of lung carcinoma. Therefore, this comprehensive review delves into the evolving field of nano-based therapeutics, shedding light on their potential to transform lung cancer treatment. This study meticulously explores the most promising nano-based strategies that have been extensively linked with the treatment of lung carcinoma and mainly emphasizes targeted drug delivery methods and therapies. Additionally, this review encapsulates the favorable results of clinical trials, which support the potential pathways for further development of nanotherapeutics in lung cancer management.
Insights
Nanotechnology offers new hope for lung cancer treatment by improving targeted drug delivery. This review explores promising nano-based strategies and clinical trial results for better lung cancer prognosis and diagnosis.
Area of Science:
- Oncology
- Nanomedicine
- Biotechnology
Background:
- Lung cancer presents significant challenges in diagnosis and treatment, with conventional methods showing limitations.
- Existing therapeutic strategies, especially targeted drug delivery, require enhancement for better patient outcomes.
- Early diagnosis and effective prognosis remain critical unmet needs in lung cancer management.
Purpose of the Study:
- To review the advancements in nano-based therapeutics for lung cancer.
- To highlight the potential of nanotechnology in targeted drug delivery for lung carcinoma.
- To explore innovative diagnostic and prognostic applications of nanomedicine in lung cancer.
Main Methods:
- Comprehensive literature review of nano-based strategies in lung cancer treatment.
- Focus on targeted drug delivery systems and their efficacy.
- Analysis of clinical trial data supporting nanotherapeutics.
Main Results:
- Nanotechnology provides novel tools for targeted drug delivery at the atomic and molecular levels.
- Emerging nano-based strategies show promise in improving lung cancer treatment efficacy.
- Clinical trials indicate favorable outcomes and potential for nanotherapeutics.
Conclusions:
- Nanotechnology is revolutionizing lung cancer research, offering improved targeted drug delivery.
- Nano-based therapeutics present a significant advancement for lung cancer prognosis and diagnosis.
- Further development of nanomedicine holds great potential for transforming lung cancer management.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Tumor Immunotherapy